[18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab.
Saved in:
| Title: | [18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab. |
|---|---|
| Authors: | Barajas RF Jr; Department of Radiology, Neuroradiology Section, Oregon Health & Science University, Portland Oregon, USA.; Knight Cancer Institute Translational Oncology Program, Oregon Health & Science University, Portland, Oregon, USA., Ambady P; Neuro-Oncology and Blood-Brain Barrier Program, Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA., Link J; Center for Radiochemistry Research, Oregon Health & Science University, Portland, Oregon, USA., Krohn KA; Center for Radiochemistry Research, Oregon Health & Science University, Portland, Oregon, USA., Raslan A; Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA., Mallak N; Advanced Imaging Research Center, Oregon Health & Science University, Portland Oregon, USA., Woltjer R; Department of Pathology, Oregon Health & Science University, Portland, Oregon, USA., Muldoon L; Neuro-Oncology and Blood-Brain Barrier Program, Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA., Neuwelt EA; Neuro-Oncology and Blood-Brain Barrier Program, Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.; Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA.; Office of Research and Development, Portland Veterans Affairs Medical Center, Portland, Oregon, USA. |
| Source: | Neuro-oncology practice [Neurooncol Pract] 2022 Mar 09; Vol. 9 (3), pp. 246-250. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101640528 Publication Model: eCollection Cited Medium: Print ISSN: 2054-2577 (Print) Linking ISSN: 20542577 NLM ISO Abbreviation: Neurooncol Pract Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2054-2577 |
|---|---|
| DOI: | 10.1093/nop/npac021 |
